| Nizatidine, Axid
Axid (Nizatidine) is a histamine H2-receptor antagonist that inhibits stomach acid production.
H2 antagonist, decreases stomach acid
Axid is indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks.
Axid is indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. The consequences of continuous therapy with Axid for longer than 1 year are not known.
Axid is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to GERD.
Axid is indicated for up to 8 weeks for the treatment of active benign gastric ulcer. Before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.
agitation, delirium, depression, diaphoresis, diarrhea, dizziness, elevated hepatic enzymes, fever, hallucinations, headache, hepatitis, jaundice, nausea/vomiting, paranoia, pruritus, urticaria,
Magnesium (often found in antacids) may reduce the absorption of H2 antagonists. Take at a different time of day.
Folate absorption is best in an acidic environment. H2 antagonists reduce stomach acid which can lower folate absorption.
Vitamin B12 absorption may be impaired by H2 antagonists, which reduce stomach acid.
Iron and Zinc
Iron and Zinc absorption is inhibited by reduced stomach acid levels.
Fantastic new books!
CAM Therapies has studies on natural therapies for over 100 diseases.
CAM Labs lists lab tests for 100 diseases.
Nutritional Genetics is a fantastic resource.